Biovian's CEO, Mr Sakari Heyno, will be available for the face to face partnering offered at the conference. To request a meeting please contact Mr. Sakari Heyno at sakari.heyno@biovian.com or at the BIO 2008 conference partnering website. ABOUT BIOVIAN Biovian
MEDAVERA program of experts to review best-practice identification, testing, and treatment of patients suffering from hypertension, atherosclerosis, and heart failure in order to improve qualities of care and life (PRWeb Apr 21, 2008) Read the full story at http://ww1.prweb.com/releases/2008/04/prweb875704.htm
High-tech firm retains top industry standard for 7th consecutive year. (PRWeb Apr 21, 2008) Read the full story at http://ww1.prweb.com/releases/2008/04/prweb871074.htm
Washington University School of Medicine in St Louis and AstraZeneca have announced a research collaboration that aims to develop new and improved ways to diagnose and treat Alzheimer's disease.
Calypte Biomedical has announced that its Chinese subsidiary, Beijing Marr Bio-Pharmaceutical, has received registration and marketing approval for Calypte's Aware HIV-1/2 OMT rapid test from the State Food and Drug Administration of China.
Synergetics USA has filed a civil, antitrust lawsuit in the US District Court of New York, against Swiss-based Alcon, and its primary operating subsidiary in the US, Alcon Laboratories.
The University of North Carolina at Chapel Hill and The Hamner Institutes for Health Sciences have signed a memorandum of understanding that will guide innovative collaborations in basic and translational research.
US based Encorium Group has announced the resignation of Lawrence Hoffman, the company's CFO, effective May 2, 2008. Mr Hoffman has decided to leave the company to pursue other interests.
Upstream Biosciences has announced that the company's novel drug candidates to treat the parasitic disease trypanosomiasis have demonstrated good safety profiles in their first in vivo toxicity tests.
